skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The linguistic turn recent essays in philosophical method
Material Type:
Livro 		Adicionar ao Meu Espaço

The linguistic turn recent essays in philosophical method

Richard Rorty editor

Chicago University of Chicago Press 1967

Localização: FEA - Fac. Econ. Adm. Contab. e Atuária  ACERVO DELFIM NETTO  (B20.25.1 )(Acessar)

2
Evidence supporting that the attribution of first success in use of arsenic for the treatment of leukaemia should be to David Lissauer (1836-1892)
Evidence supporting that the attribution of first success in use of arsenic for the treatment of leukaemia should be to David Lissauer (1836-1892)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evidence supporting that the attribution of first success in use of arsenic for the treatment of leukaemia should be to David Lissauer (1836-1892)

Manley, Paul W

Leukemia, 2022-06, Vol.36 (6), p.1697-1698 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase
Material Type:
Artigo 		Adicionar ao Meu Espaço

The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase

Manley, Paul W. ; Barys, Louise ; Cowan-Jacob, Sandra W.

Leukemia research, 2020-11, Vol.98, p.106458, Article 106458 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1

Schoepfer, Joseph ; Jahnke, Wolfgang ; Berellini, Giuliano ; Buonamici, Silvia ; Cotesta, Simona ; Cowan-Jacob, Sandra W ; Dodd, Stephanie ; Drueckes, Peter ; Fabbro, Doriano ; Gabriel, Tobias ; Groell, Jean-Marc ; Grotzfeld, Robert M ; Hassan, A. Quamrul ; Henry, Chrystèle ; Iyer, Varsha ; Jones, Darryl ; Lombardo, Franco ; Loo, Alice ; Manley, Paul W ; Pellé, Xavier ; Rummel, Gabriele ; Salem, Bahaa ; Warmuth, Markus ; Wylie, Andrew A ; Zoller, Thomas ; Marzinzik, Andreas L ; Furet, Pascal

Journal of medicinal chemistry, 2018-09, Vol.61 (18), p.8120-8135 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por
5
Investigations into the Potential Role of Metabolites on the Anti-Leukemic Activity of Imatinib, Nilotinib and Midostaurin
Investigations into the Potential Role of Metabolites on the Anti-Leukemic Activity of Imatinib, Nilotinib and Midostaurin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Investigations into the Potential Role of Metabolites on the Anti-Leukemic Activity of Imatinib, Nilotinib and Midostaurin

Manley, Paul W

Chimia, 2019-08, Vol.73 (7-8), p.561-570 [Periódico revisado por pares]

Switzerland: Swiss Chemical Society

Texto completo disponível

Citações Citado por
6
Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles
Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles

Kisilevsky, Robert ; Manley, Paul N.

Amyloid, 2012-03, Vol.19 (1), p.5-14 [Periódico revisado por pares]

England: Informa Healthcare

Texto completo disponível

Citações Citado por
7
Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering
Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering

Fu, Dan ; Zhou, Jing ; Zhu, Wenjing Suzanne ; Manley, Paul W ; Wang, Y Karen ; Hood, Tami ; Wylie, Andrew ; Xie, X Sunney

Nature chemistry, 2014-07, Vol.6 (7), p.614-622 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood–brain barrier
A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood–brain barrier
Material Type:
Artigo 		Adicionar ao Meu Espaço

A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood–brain barrier

Manley, Paul W. ; Huth, Felix ; Moussaoui, Saliha ; Schoepfer, Joseph

Bioorganic & medicinal chemistry letters, 2022-03, Vol.59, p.128577-128577, Article 128577 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib

Day, Elizabeth ; Waters, Beatrice ; Spiegel, Katrin ; Alnadaf, Tanja ; Manley, Paul W. ; Buchdunger, Elisabeth ; Walker, Christoph ; Jarai, Gabor

European journal of pharmacology, 2008-12, Vol.599 (1), p.44-53 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
10
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

Griffin, James D ; Weisberg, Ellen ; Manley, Paul W ; Cowan-Jacob, Sandra W ; Hochhaus, Andreas

Nature reviews. Cancer, 2007-05, Vol.7 (5), p.345-356 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (551)
  2. Web Resources  (25)
  3. Book Chapters  (11)
  4. Reports  (8)
  5. Anais de Congresso  (8)
  6. Resenhas  (5)
  7. Conjunto de Dados  (4)
  8. Livros  (1)
  9. Outros  (1)
  10. Dissertações  (1)
  11. Mais opções open sub menu

Idioma 

  1. Inglês  (613)
  2. Japonês  (73)
  3. Alemão  (3)
  4. Norueguês  (3)
  5. Francês  (1)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Rorty, R

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Animals
  5. Male

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.